Leukemia Acute Myeloid M0 Subtype C1835434
An aggressive form of blood cancer affecting myeloid blood cells. Usually occurs in adults and is treated with intensive chemotherapy, often followed by transplant.
Key facts at a glance
- ICD-10
- C96.9
- ICD-11
- 2A00.0
- Body system
- hematologic
- Severity
- critical
- Chronic
- false
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Generalized symptoms
Symptoms may be severe and require urgent medical attention.
Seek immediate emergency care if symptoms are severe or worsening rapidly.
Severe headache
Fatigue
(general)Easy bruising
(hematologic)Fever
(general)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Induction Chemotherapy (7+3 Regimen)
Intensive cytarabine combined with an anthracycline (daunorubicin or idarubicin) represents the standard induction therapy for AML, aiming to achieve complete remission through eradication of leukemic blasts.
Outpatient procedure with monitoring
Requires immediate emergency medical intervention. Do not delay treatment.
Consolidation Chemotherapy
Additional intensive chemotherapy cycles following induction to eliminate residual disease and prevent relapse, with high-dose cytarabine being a common backbone.
Additional treatment options
Allogeneic Stem Cell Transplant
Potentially curative approach for high-risk patients using donor stem cells, providing both tumor-free graft and graft-versus-leukemia effect.
surgicalTargeted Therapy (FLT3 Inhibitors)
For patients with FLT3 mutations common in AML, tyrosine kinase inhibitors like midostaurin or gilteritinib may be added to standard chemotherapy or used as maintenance.
medicationMinimal Residual Disease Monitoring
Highly sensitive molecular and flow cytometry techniques detect residual leukemia cells below morphological detection threshold, guiding treatment intensity decisions.
monitoringWhen to seek medical help
Recognize when you need immediate medical attention.
Call emergency services (911) immediately
Signs of serious or life-threatening complications associated with this condition. Immediate medical evaluation is required.
Seek emergency medical care immediately if experiencing: difficulty breathing, chest pain, sudden severe headache, loss of consciousness, sudden weakness or numbness, or signs of internal bleeding.
Frequently asked questions
Common questions about this topic.
What is Leukemia Acute Myeloid M0 Subtype C1835434?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Dohner H, Estey EH, Amadori S. Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel. Blood. 2022.
Arber DA, Orazi A, Hasserjian RP. The 5th edition of the World Health Organization classification of hematopoietic and lymphoid tumors. Haematologica. 2023.
Wei AH, Tiong IS, Roulstone V. Molecular minimal residual disease detection in acute myeloid leukemia with NPM1 mutations. J Clin Oncol. 2023.
Short NJ, Rausch SR, Kantarjian HM. Blasts with minimal differentiation: clinicopathological features and outcomes in acute myeloid leukemia. Leukemia Research. 2021.
Medication Comparisons
Compare medications used to treat Leukemia Acute Myeloid M0 Subtype C1835434. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy